EVOK Evoke Pharma Inc

Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.

$3.05  -0.03 (-0.97%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  09/25/2013
Outstanding shares:  40,116,877
Average volume:  2,270,356
Market cap:   $123,559,981
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -15.09
PB ratio:   51.69
PS ratio:   121.66
Return on equity:   -419.14%
Net income %:   -798.17%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy